AAAAAA

   
Results: 1-9 |
Results: 9
Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells
Authors: Pardo, OE Arcaro, A Salerno, G Tetley, TD Valovka, T Gout, I Seckl, MJ
Citation: Oe. Pardo et al., Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells, ONCOGENE, 20(52), 2001, pp. 7658-7667
Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles
Authors: Paradinas, FJ Sebire, NJ Fisher, RA Rees, HC Foskett, M Seckl, MJ Newlands, ES
Citation: Fj. Paradinas et al., Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles, HISTOPATHOL, 39(5), 2001, pp. 447-454
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options
Authors: Francis, R Bower, M Brunstrom, G Holden, L Newlands, ES Rustin, GJS Seckl, MJ
Citation: R. Francis et al., Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options, EUR J CANC, 36(15), 2000, pp. 1925-1932
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors
Authors: Newlands, ES Mulholland, PJ Holden, L Seckl, MJ Rustin, GJS
Citation: Es. Newlands et al., Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors, J CL ONCOL, 18(4), 2000, pp. 854-859
Choriocarcinoma and partial hydatidiform moles
Authors: Seckl, MJ Fisher, RA Salerno, G Rees, H Paradinas, FJ Foskett, M Newlands, ES
Citation: Mj. Seckl et al., Choriocarcinoma and partial hydatidiform moles, LANCET, 356(9223), 2000, pp. 36-39
A molecular cytogenetic approach to studying platinum resistance
Authors: Hiorns, LR Seckl, MJ Paradinas, F Sharp, SY Skelton, LA Brunstrom, G Newlands, ES Kelland, LR Leyland-Jones, B
Citation: Lr. Hiorns et al., A molecular cytogenetic approach to studying platinum resistance, J INORG BIO, 77(1-2), 1999, pp. 95-104
Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics
Authors: Lo, SK Montgomery, JN Blagden, S McNeish, IA Agarwal, R Suntharalingam, J Seckl, MJ Newlands, ES
Citation: Sk. Lo et al., Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics, LANCET, 353(9169), 1999, pp. 2038-2039
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix
Authors: Seckl, MJ Mulholland, PJ Bishop, AE Teale, JD Hales, CN Glaser, M Watkins, S Seckl, JR
Citation: Mj. Seckl et al., Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix, N ENG J MED, 341(10), 1999, pp. 733-736
The management and outcome in patients presenting with twin/multiple pregnancies complicated by a complete hydatidiform mole (CHM) and patients presenting with partial hydatidiform mole (PHM)
Authors: Newlands, ES Foskett, MA Seckl, MJ Paradinas, FJ Francis, R Short, D Fuller, S Hall, JF
Citation: Es. Newlands et al., The management and outcome in patients presenting with twin/multiple pregnancies complicated by a complete hydatidiform mole (CHM) and patients presenting with partial hydatidiform mole (PHM), 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 43-47
Risultati: 1-9 |